Antihistamines & Postacute Sequelae of SARS-CoV-2: A Case Study

  • Context: COVID 
  • Thread starter Thread starter Tom.G
  • Start date Start date
  • Tags Tags
    Study
Join the discussion
Registration is free. Ask a follow-up in this thread, or start your own.
1 reply · 1K views
Science Advisor
Gold Member
Messages
5,661
Reaction score
4,508
I know, it's a weasel-worded thread title.
The Journal article is titled:

Antihistamines for Postacute Sequelae of SARS-CoV-2 Infection​

We describe 2 cases of PASC in response to opportune administration of over-the-counter antihistamines, with significant improvement in symptoms and ability to perform activities of daily living. Future studies are warranted...

Popular article:
https://www.sciencealert.com/there-s-evidence-antihistamines-may-help-treat-long-covid-symptoms

Journal article:
https://doi.org/10.1016/j.nurpra.2021.12.016

Cheers,
Tom
 
Reply
  • Like
Likes   Reactions: jim mcnamara
Biology news on Phys.org
Hi Tom,

Thanks for sharing this article about the potential use of antihistamines to treat postacute sequelae of SARS-CoV-2 infection (PASC). The evidence presented in the journal article looks promising. I'm interested in seeing what further studies are conducted on this topic. Have you seen any other research on this topic?

Thanks again!